ERBB2 and non-small cell lung carcinoma: In this context, HER2 gene amplification, protein overexpression, and mutations represent an interesting area of oncogene addiction models of NSCLC, mainly in EGFR/KRAS/ALK-mutation-negative patients (Figure 1) [26].